Frontiers review
NO in the lung

https://doi.org/10.1016/0034-5687(95)00016-7Get rights and content

Abstract

In the lung, nitric oxide (NO) derives from several cellular sources, forming networks of paracrine communication. In pulmonary vessels, NO produced by endothelial cells is a powerful vasodilator. In the airways, NO originates from epithelial cells and from adventitial nerve endings to induce smooth muscle relaxation. Activated macrophages can also produce large quantities of NO during lung immunological reactions. In the normal pulmonary circulation, NO not only mediates vasodilation, but also opposes vasoconstriction, prevents platelet adhesion, controls growth of smooth muscle and influences the composition of the extracellular matrix. During exposure to chronic hypoxia, impaired endothelial NO production contributes to the increased vasomotor tone and vascular remodelling leading to sustained pulmonary hypertension. Exogenous NO gas delivered via the airspaces is a selective pulmonary vasodilator. Inhaled NO is now used as a therapy to treat various forms of pulmonary hypertension and to improve arterial oxygenation during lung injury.

References (32)

  • S. Archer et al.

    Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium-derived relaxing factor

    Biochem. Biophys. Res. Commun.

    (1989)
  • J. Pepke-Zaba et al.

    Inhaled nitric oxide as a cause of selective pulmonary hypertension

    Lancet

    (1991)
  • S. Adnot et al.

    Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia

    J. Clin. Invest.

    (1991)
  • S. Adnot et al.

    Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension

    Am. Rev. Respir. Dis.

    (1993)
  • V.L. Brashers et al.

    Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation

    J. Clin. Invest.

    (1988)
  • C. Carville et al.

    Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine

    J. Cardiovasc. Pharmacol.

    (1993)
  • A.T. Dinh Xuan et al.

    Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease

    N. Engl. J. Med.

    (1991)
  • P. Dupuy et al.

    Bronchodilator action of inhaled nitric oxide in guinea pigs

    J. Clin. Invest.

    (1992)
  • S. Eddahibi et al.

    L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats

    Am. J. Physiol.

    (1992)
  • C. Frostell et al.

    Inhaled nitric oxide, a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction

    Circulation

    (1991)
  • R.F. Furchgott et al.

    The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

    Nature

    (1980)
  • U.C. Garg et al.

    Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

    J. Clin. Invest.

    (1989)
  • B. Gaston et al.

    The biology of nitrogen oxides in the airways

    Am. J. Respir. Crit. Care. Med.

    (1994)
  • A. Giaid et al.

    Nitric oxide synthase and endothelin-1 activities in lung of patients with pulmonary hypertension

    Eur. Respir. J.

    (1994)
  • G. Gibbons et al.

    The emerging concept of vascular remodeling

    N. Engl. J. Med.

    (1994)
  • V. Hampl et al.

    Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure

    J. Appl. Physiol.

    (1993)
  • Cited by (66)

    • Ventilation causes pulmonary vascular dilation and modulates the NOS and VEGF pathway on newborn rats with CDH

      2015, Journal of Pediatric Surgery
      Citation Excerpt :

      Our results showed a decrease of NOS2 expression in CDH group after ventilation, as reported in the study above. Considering that NOS2 is activated by inflammatory stimuli [52], we would expect that the change from a hypoxic intrauterine environment to a relatively hyperoxic as seen in our study, would lead to an overflow of free radicals by the production of superoxide and H2O2 [40], resulting in activation of the inflammatory cascade and upregulation of NOS2. The endothelium is the main regulator of vascular tone by producing vasodilators.

    • The effects of respiratory muscle training on respiratory mechanics and energy cost

      2014, Respiratory Physiology and Neurobiology
      Citation Excerpt :

      One potential contributor to increased exercise performance and increased respiratory efficiency in particular is the possibility of increased nitric oxide (NO) levels in the airways. NO is a potent bronchodilator (Adnot et al., 1995), and higher exhaled levels have been observed in athletes (Maroun et al., 1995) and during exercise (Chirpaz-Oddou et al., 1997; Maroun et al., 1995) and heavy breathing (West et al., 2005). While these results must be interpreted cautiously—higher exhaled NO concentration does not necessarily indicate higher rates of production—they at least suggest a link between airway NO levels, work of breathing, and subject fitness, which may be of particular interest when considering the effects of RMT.

    • Current Knowledge of Acute Lung Injury and Acute Respiratory Distress Syndrome

      2012, Critical Care Nursing Clinics of North America
      Citation Excerpt :

      Exogenous NO gas delivered via the airspaces is a selective pulmonary vasodilator in aerated portions of the lung, which cause blood flow to redistribute toward ventilated areas. This results in improved matching of perfusion to ventilation, and therefore arterial oxygenation, without causing concomitant systemic vasodilation.110–116 The effect of NO on oxygenation and pulmonary artery pressure may allow more time for the lungs to recover.

    View all citing articles on Scopus
    View full text